Pharsight

Drug patents opposed in 2020

Drug patents opposed in 2020 at the European Patent Office (EPO).

Patent Number Patent Title Company Recent Opposition Date Recent Opposition By Activity Alert
EP3236939B1 Botulinum toxin prefilled container MERZ PHARMA 31 Dec, 2020
ALLERGAN
EP3470059B1 Ophthalmic suspension composition BAUSCH & LOMB INCORPORATED 30 Dec, 2020
SANDOZ
EP3136861B1 Composition containing peroxide and an antimicrobial agent and process of killing spores AMERICAN STERILIZER CO 29 Dec, 2020
(Expiration: Feb, 2035)
BODE CHEMIE
EP2309876B1 Nutritional composition containing oligosaccharide mixture SOCIT DES PRODUITS NESTL 24 Dec, 2020
NUTRICIA
(and 1 more)
EP3383366B1 Pharmaceutical composition MEXICHEM FLUOR DE CV 23 Dec, 2020
BECK GREENER
EP3041581B1 Hair care composition comprising amino silicone, fatty alcohol and paraffin oil ALVES DIEGO M 23 Dec, 2020
(Expiration: Sep, 2033)
HENKEL
EP3191081B1 Formulation comprising glycopyrrolate, method and apparatus VECTURA 22 Dec, 2020
BECK GREENER
EP3268337B1 Methods and kits for preparing radionuclide complexes THERAGNOSTICS 22 Dec, 2020
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
EP3423028B1 Method for the production of encapsulated fragrance with improved stability against detergents SYMRISE AG 22 Dec, 2020
(Expiration: Feb, 2036)
VO
(and 1 more)
EP2395983B1 Pharmaceutical composition comprisng a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH 22 Dec, 2020
(Expiration: Feb, 2030)
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 2 more)
EP3043797B1 Treating infections with ceftolozane/tazobactam in subjects having impaired renal function MERCK SHARP & DOHME 21 Dec, 2020
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3199164B1 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom GLAXO GROUP 18 Dec, 2020
ADAMSON JONES
EP2928454B1 New treatments with triazines CEVA SANT ANIMALE 18 Dec, 2020
ELANCO
(and 1 more)
EP3389604B1 Composition comprising a combination of particular alkoxysilanes and a fatty substance LOREAL 18 Dec, 2020
HENKEL
EP3412687B1 Methods for treating dlbcl AMGEN RESEARCH MUNICH 18 Dec, 2020
JAMES POOLE
EP3102187B1 Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets GALENICUM HEALTH SLU 17 Dec, 2020
ELKINGTON AND FIFE
(and 6 more)
EP3437627B1 2-propylheptylocanoat in cosmetic preparations BEIERSDORF 17 Dec, 2020
LOREAL
EP2094246B1 Sustained-release composition and method for producing the same TAKEDA PHARMACEUTICAL 16 Dec, 2020
INSTONE TERRY READ HOWARD GRAHAM APPLEYARD LEES
EP2545777B2 Isoxazoline compositions and their use as antiparasitics INTERVET 11 Dec, 2020
CEVA SANTE ANIMALE
(and 1 more)
EP2139494B1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate ASTRAZENECA 11 Dec, 2020
(Expiration: Mar, 2028)
KRAUS & WEISERT PATENTANWLTE PARTGMBB
(and 5 more)
EP2708147B1 Methods for increasing brain functionality using 2-fucosyl-lactose ABBOTT LABORATORIES 11 Dec, 2020
(Expiration: Sep, 2032)
NUTRICIA
(and 2 more)
EP2802333B1 Lactobacillus rhamnosus and bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections CHR HANSEN 10 Dec, 2020
DUPONT NUTRITION BIOSCIENCES APS
EP3087098B1 Anti-vista antibodies and fragments JANSSEN PHARMACEUTICA NV 10 Dec, 2020
(Expiration: Dec, 2034)
MARGARET DIXON
(and 1 more)
EP3395338B1 Rapid dissolution formulation of cinacalcet hcl AMGEN INC 09 Dec, 2020
(Expiration: Sep, 2024)
BETAPHARM ARZNEIMITTEL
(and 6 more)
EP3562467B2 An antimicrobial composition UNILEVER 07 Dec, 2020
HENKEL
EP2978446B1 Anti-cd33 antibody for use in treating alzheimer's disease GENERAL HOSPITAL CORP 04 Dec, 2020
(Expiration: Mar, 2034)
ABBVIE
(and 2 more)
EP3126373B1 Method for preparing amg 416 AMGEN 04 Dec, 2020
COPA COPENHAGEN PATENTS KS
EP3453378B1 A cosmetic gel composition SOCIET ITALO BRITANNICA L MANETTI H ROBERTS & CPA 04 Dec, 2020
HENKEL
EP3231805B1 Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt CRYSTAL PHARMATECH CO LTD 04 Dec, 2020
(Expiration: Dec, 2035)
SAGITTARIUS CONSULTANTS
EP3492109B1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof MODERNATX INC 04 Dec, 2020
(Expiration: Oct, 2032)
SANOFI
(and 1 more)
EP3326620B1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2- hydroxybenzoyl)amino)caprylic acid NOVO NORDISK AS 03 Dec, 2020
(Expiration: Dec, 2031)
HEXAL
(and 3 more)
EP3280416B1 Dosing regimen for missed doses for long-acting injectable paliperidone esters JANSSEN PHARMACEUTICALS INC 01 Dec, 2020
(Expiration: Mar, 2036)
INSTONE
(and 7 more)
EP3219324B1 Application of dipeptide as ace enzyme activity inhibitor WITHYOU BIOTECHNOLOGY CO LTD 26 Nov, 2020
(Expiration: Aug, 2034)
DANNER
EP3338794B1 Toxicity management for anti-tumor activity of cars CHILDRENS HOSPITAL OF PHILADELPHIA CHOP 25 Nov, 2020
(Expiration: Jul, 2033)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 6 more)
EP2207597B1 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY 19 Nov, 2020
(Expiration: Sep, 2028)
EUROPEAN OPPOSITIONS
EP3398446B1 Edible composition comprising bifidobacterium longum SOCIETE DES PRODUITS NESTLE SA 18 Nov, 2020
(Expiration: Apr, 2029)
MORINAGA MILK INDUSTRY
EP3319622B1 Method for producing rna molecule compositions CUREVAC AG 12 Nov, 2020
(Expiration: Dec, 2036)
BIONTECH RNA PHARMACEUTICALS
EP3188713B1 Method of inducing satiety PERORA 12 Nov, 2020
DSM NUTRITIONAL PRODUCTS
EP2675423B1 Pigment mixtures for cosmetics BASF 12 Nov, 2020
ECKART
EP3236918B2 Use of a fatty acid ester for mattifying the skin and composition comprising this ester LOREAL 12 Nov, 2020
HENKEL
EP2752488B1 Antisense design ROCHE INNOVATION CENTER COPENHAGEN AS 12 Nov, 2020
(Expiration: Nov, 2023)
IONIS PHARMACEUTICALS
EP3023788B1 Compositions of tumor specific neoantigens THE GENERAL HOSPITAL 12 Nov, 2020
JAMES POOLE
EP3512603B1 Compressed hair spray UNILEVER 12 Nov, 2020
LOREAL
EP3104844B1 Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them DRUGGABILITY TECHNOLOGIES IP HOLDCO LTD 11 Nov, 2020
(Expiration: Feb, 2035)
ALKERMES PHARMA IRELAND
EP2328634B1 Infusion systems including computer-facilitated maintenance and/or operation BRACCO DIAGNOSTICS 11 Nov, 2020
JUBILANT DRAXIMAGE
EP3003284B1 Pharmaceutical formulations of a hif hydroxylase inhibitor FIBROGEN 11 Nov, 2020
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP2986157B1 Fermented nutritional composition with thiol protease inhibitor NUTRICIA 05 Nov, 2020
SOCIT DES PRODUITS NESTL
EP3077058B1 Composition comprising at least one anionic associative polymer, at least one anionic fixing polymer and at least one cationic fixing polymer LORAL 03 Nov, 2020
HENKEL
EP3366352B1 Waterproof, sprayable sun protection agent BEIERSDORF 29 Oct, 2020
STADA ARZNEIMITTEL
EP3258951B1 Anti-pvrig antibodies and methods of use COMPUGEN 29 Oct, 2020
WITEK
(and 1 more)
EP3344289B1 Pestivirus vaccines for congenital tremors BOEHRINGER INGELHEIM VETMEDICA GMBH 28 Oct, 2020
(Expiration: Aug, 2036)
INTERVET
EP3227454B1 Process for manipulating the level of glycan content of a glycoprotein AMGEN 28 Oct, 2020
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
(and 4 more)
EP3173129B1 Sunscreen comprising titanium dioxide and ethylhexyl salicylate BEIERSDORF AG 27 Oct, 2020
(Expiration: Nov, 2036)
DSM NUTRITIONAL PRODUCTS
(and 3 more)
EP3131912B1 Process for efficient purification of neutral human milk oligosaccharides (hmos) from microbial fermentation CHR HANSEN HMO 22 Oct, 2020
BASF
(and 5 more)
EP2785702B1 Crystalline dapagliflozin hydrate SANDOZ 22 Oct, 2020
GENERICS UK TRADING MYLAN
EP2258355B1 Patch HISAMITSU PHARMACEUTICAL 21 Oct, 2020
LTS LOHMANN THERAPIE SYSTEME
EP2790681B9 Polymer protein microparticles REGENERON PHARMACEUTICALS 21 Oct, 2020
WITHERS & ROGERS
EP3275871B1 Crystals NIPPON SHINYAKU 15 Oct, 2020
GENERICS UK
EP3076996B1 Vaccine against porcine circo virus type 2 INTERVET 14 Oct, 2020
ELANCO
(and 1 more)
EP2919761B1 Solid dosage form comprising micronized cytisine AFLOFARM FARMACJA POLSKA SP Z OO 14 Oct, 2020
REDDIE & GROSE
EP2957552B1 Vilanterol formulations ARVEN ILAC SANAYI VE TICARET AS 13 Oct, 2020
(Expiration: Jun, 2035)
GILL JENNINGS & EVERY
(and 2 more)
EP2957551B1 Dry powder formulations comprising vilanterol ARVEN ILAC SANAYI VE TICARET AS 12 Oct, 2020
(Expiration: Jun, 2035)
GILL JENNINGS & EVERY
(and 3 more)
EP3150586B1 Modulators of pharmacokinetic properties of therapeutics GILEAD SCIENCES 08 Oct, 2020
COOKE
(and 2 more)
EP2640371B1 Vasoprotective and cardioprotective antidiabetic therapy BOEHRINGER INGELHEIM INTERNATIONAL GMBH 08 Oct, 2020
(Expiration: Nov, 2031)
GALENICUM HEALTH SLU
(and 1 more)
EP3307393B1 Fragrance composition PROCTER AND GAMBLE CO 08 Oct, 2020
(Expiration: Jun, 2036)
HENKEL
EP2359815B1 Compositions comprising amlodipine and bisoprolol EGIS GYGYSZERGYR ZRT 08 Oct, 2020
KRKA
EP2197287B1 Use of a bifidobacterium strain for preparing a composition for preventing and/or treating allergic manifestations COMPAGNIE GERVAIS DANONE 08 Oct, 2020
SOCIT DES PRODUITS NESTL
EP3127427B1 Methods of administration of thrombopoietin agonist compounds NOVARTIS AG 08 Oct, 2020
(Expiration: May, 2030)
ZENTIVA KS
(and 1 more)
EP2921155B1 High-quality lipids and methods for producing by enzymatic liberation from biomass DSM ASSETS 07 Oct, 2020
ELKINGTON AND FIFE
EP2985018B1 Anti-discoloration composition SENSIENT COSMETIC 07 Oct, 2020
GARCA
EP3258919B2 Nasal powder formulation for treatment of hypoglycemia ELI LILLY 05 Oct, 2020
ELKINGTON AND FIFE
EP3354276B1 Compositions for the treatment of gastrointestinal inflammation MERITAGE PHARMA INC 01 Oct, 2020
(Expiration: Nov, 2028)
AECHTER
(and 1 more)
EP3215173B8 Glycopeptide compositions XELLIA PHARMACEUTICALS APS 01 Oct, 2020
(Expiration: Nov, 2035)
DF MP DRRIES FRANK MOLNIA & POHLMAN
EP3071040B2 Method for scalable skeletal muscle lineage specification and cultivation THE CURATORS OF THE UNIVERSITY OF MISSOURI 01 Oct, 2020
GLEISS GROE SCHRELL UND PARTNER MBB
EP3103463B1 Adherent cells from adipose or placenta tissues and use thereof in therapy PLURISTEM 01 Oct, 2020
ICOSA EUROPE
(and 1 more)
EP3294279B1 Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy PROFESSIONAL DIETETICS 01 Oct, 2020
NUTRICIA
EP3431105B1 Medicinal composition for treating cancer SHIONOGI 30 Sep, 2020
GLAXOSMITHKLINE
(and 4 more)
EP3166628B2 Therapeutic use of bone morphogenetic proteins CAMBRIDGE ENTERPRISE 30 Sep, 2020
JAMES POOLE
EP2674147B1 Method of preparing a hyaluronic acid-based gel including lidocaine HCl. ALLERGAN INDUSTRIE SAS 30 Sep, 2020
(Expiration: Mar, 2029)
MERZ PHARMA
(and 1 more)
EP2756004B1 Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9) REGENERON PHARMACEUTICALS 25 Sep, 2020
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB
(and 1 more)
EP3373901B1 Dentifrice compositions with improved fluoride uptake THE PROCTER & GAMBLE 25 Sep, 2020
COLGATE PALMOLIVE
EP3173130B1 Sunscreen comprising titanium dioxide and octocrylene BEIERSDORF AG 25 Sep, 2020
(Expiration: Nov, 2036)
DSM NUTRITIONAL PRODUCTS
(and 3 more)
EP2773748B1 Midbrain dopamine (da) neurons for engraftment MEMORIAL SLOAN KETTERING CANCER CENTER 25 Sep, 2020
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3220751B1 Complexes of whey protein micelles and pectin and body muscle protein synthesis SOCIT DES PRODUITS NESTL 25 Sep, 2020
NUTRICIA
EP3134432B1 Mnd promoter chimeric antigen receptors SEVENTY BIO 25 Sep, 2020
PATENT BOUTIQUE
EP3124046B1 Combination therapies employing gitr binding molecules GITR 25 Sep, 2020
SANOFI
EP3054784B2 Composition and fodder comprising medium chain fatty acids NUTRITION SCIENCES 24 Sep, 2020
NUTRECO ASSETS
EP3189073B1 Trophoblast glycoprotein (5t4, tpbg) specific chimeric antigen receptors for cancer immunotherapy CELLECTIS 24 Sep, 2020
OXFORD BIOMEDICA UK
EP3030249B1 Antibodies, compounds and derivatives thereof for use in the treatment of male infertility FERTILITYPRO APS 24 Sep, 2020
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
EP2683245B2 Methods and compositions for treating depression using cyclobenzaprine TONIX PHARMA 23 Sep, 2020
HEXAL
EP2535044B1 Enterically coated cysteamine, cystamine and derivatives thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 18 Sep, 2020
ALFRED E TIEFENBACHER
EP2869844B2 Treatment for bone diseases UCB PHARMA 18 Sep, 2020
JAMES POOLE
EP2827835B2 Superabsorbent polymers and silicone elastomer for use in skin care compositions THE PROCTER & GAMBLE 18 Sep, 2020
LORAL
(and 1 more)
EP3388070B1 Extensional viscosity to promote safe swallowing of food boluses SOCIETE DES PRODUITS NESTLE SA 18 Sep, 2020
(Expiration: Mar, 2032)
NUTRICIA
(and 1 more)
EP2903638B1 Immunogenic composition GLAXOSMITHKLINE BIOLOGICALS SA 18 Sep, 2020
(Expiration: Oct, 2033)
PFIZER
EP2100902B1 Methods for treating pain by administering an antagonist antibody against the nerve growth factor and an opioid analgesic, and compositions containing the same RINAT NEUROSCIENCE 18 Sep, 2020
REGENERON PHARMACEUTICALS
EP3294285B1 Cabazitaxel and its use for treating cancer SANOFI MATURE IP 18 Sep, 2020
(Expiration: May, 2036)
ZENTIVA
(and 8 more)
EP2709672B1 Compositions and methods for treating retinal diseases UNIVERSITY OF CALIFORNIA 17 Sep, 2020
(Expiration: May, 2032)
RENEURON
EP3331534B1 Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants SOCIT DES PRODUITS NESTL 16 Sep, 2020
RECKITT BENCKISER HEALTH
(and 3 more)
EP3127551B1 Pcv2 immunogenic composition for lessening clinical symptoms in pigs BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC 15 Sep, 2020
(Expiration: Dec, 2026)
LABORATORIOS HIPRA
(and 2 more)
EP3075744B1 Improved recombinant human follicle-stimulating hormone GLYCOTOPE GMBH 11 Sep, 2020
(Expiration: Aug, 2031)
AUGUST DEBOUZY
EP3214095B1 Compositions and methods for modulating immune responses ZYMOGENETICS 11 Sep, 2020
F HOFFMANN LA ROCHE
(and 2 more)
EP2228064B1 Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist NOVARTIS PHARMA GMBH 11 Sep, 2020
(Expiration: May, 2025)
ORION ORION PHARMA
(and 9 more)
EP2410942B1 Curable zirconia adhesive compositions for dental restorations BISCO INC 11 Sep, 2020
(Expiration: Mar, 2029)
RIECK
EP2350096B1 Methods of treating hepatic encephalopathy SALIX PHARMACEUTICALS 11 Sep, 2020
STADA ARZNEIMITTEL
(and 7 more)
EP3088512B1 Use of placental stem cells for treating heart and circulatory diseases by promoting angiogenesis CELULARITY INC 10 Sep, 2020
(Expiration: Apr, 2031)
D YOUNG
EP2968992B8 Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride TONIX PHARMA 10 Sep, 2020
HEXAL
EP3148521B1 Fluticasone furoate in the treatment of copd GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD 08 Sep, 2020
(Expiration: May, 2035)
TEVA UK
(and 1 more)
EP2763935B2 Apparatus and method for generating nitric oxide in controlled and accurate amounts NITRICGEN 04 Sep, 2020
BOCK
EP3179980B1 Shampoo composition UNILEVER 04 Sep, 2020
LORAL
EP3218065B1 Compositions and methods for the colouring keratinic fibres HENKEL AG AND CO KGAA 04 Sep, 2020
(Expiration: Oct, 2035)
LOREAL
EP3058942B2 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions SOCIT DES PRODUITS NESTL 04 Sep, 2020
MARS
(and 1 more)
EP3054993B1 Permanent gene correction by means of nucleotide-modified messenger rna HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH 03 Sep, 2020
(Expiration: Oct, 2034)
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP2953487B1 Method to convert insects or worms into nutrient streams and compositions obtained thereby BHLER 03 Sep, 2020
YNSECT
EP3206666B1 Liquid pharmaceutical composition comprising pemetrexed SYNTHON 02 Sep, 2020
LARSEN & BIRKEHOLM
EP3335708B1 Administration of gamma hydroxybutyrate with monocarboxylate transporters JAZZ PHARMACEUTICALS IRELAND 02 Sep, 2020
ZENTIVA
(and 3 more)
EP3285725B1 Concentrated personal cleansing compositions THE PROCTER & GAMBLE 01 Sep, 2020
BEIERSDORF
(and 1 more)
EP2695609B1 Oral formulations of cytidine analogs and methods of use thereof CELGENE 30 Aug, 2020
GENERICS UK
(and 3 more)
EP3416627B9 Oral dosage form comprising rifaximin in form beta SANDOZ 27 Aug, 2020
ALFASIGMA
EP2978451B1 Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5 ALEXION PHARMACEUTICALS INC 27 Aug, 2020
(Expiration: Mar, 2034)
REGENERON PHARMACEUTICALS
(and 1 more)
EP3088373B1 Translucent zirconia sintered body and zirconia powder, and use therefor TOSOH 27 Aug, 2020
TREIBACHER INDUSTRIE
EP2596786B1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia AMARIN PHARMACEUTICALS IRELAND LTD 26 Aug, 2020
(Expiration: Feb, 2030)
HOFFMANN EITLE
(and 1 more)
EP3037089B1 Eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia AMARIN PHARMACEUTICALS IRELAND LTD 26 Aug, 2020
(Expiration: Feb, 2030)
HOFFMANN EITLE
(and 1 more)
EP3188717B1 Formulation comprising particles PERORA GMBH 21 Aug, 2020
(Expiration: Aug, 2035)
DSM NUTRITIONAL PRODUCTS
EP3456374B1 Implant syringe GAPLAST GMBH 20 Aug, 2020
(Expiration: Aug, 2038)
AMW
EP3278809B1 Safe desmopressin administration SERENITY PHARMACEUTICALS LLC 20 Aug, 2020
(Expiration: Jun, 2030)
FERRING
EP3275422B1 Aqueous hair styling composition comprising high amounts of waxes and fatty compounds KAO GERMANY 20 Aug, 2020
HENKEL
EP3272361B1 Method for producing a freeze-dried pharmaceutical composition containing mitomycin c MEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATE 20 Aug, 2020
HOLLATZ
EP3174889B1 Sofosbuvir in crystalline form and process for its preparation HC PHARMA 20 Aug, 2020
KELTIE
EP3137043B2 Sunscreen having reduced tendency to stain textiles iv BEIERSDORF 20 Aug, 2020
LOREAL
(and 1 more)
EP1827604B1 Methods and compositions for adoptive immunotherapy PETER MACCALLUM CANCER INSTITUTE 19 Aug, 2020
(Expiration: Dec, 2025)
GLAXOSMITHKLINE
(and 2 more)
EP3172319B1 Coronavirus THE PIRBRIGHT INSTITUTE 19 Aug, 2020
MUSEBENI
EP2781509B2 New polymorph of ivabradine hydrochloride and method for its preparation CHEMO RESEARCH SL 18 Aug, 2020
BOTTI & FERRARI
EP3409274B1 Dosage regimen for a s1p receptor agonist NOVARTIS AG 18 Aug, 2020
(Expiration: Dec, 2029)
VON SEEBACH
(and 1 more)
EP3409286B1 Low frequency glatiramer acetate therapy YEDA RESEARCH AND DEVELOPMENT CO LTD 17 Aug, 2020
(Expiration: Aug, 2030)
GENERICS UK
(and 1 more)
EP3363807B1 Pharmaceutical composition comprising crystalline (2s,3r,4s,5s,6r)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (s)-propylene glycol solvate ASTRAZENECA 13 Aug, 2020
(Expiration: Jun, 2027)
GENERICS UK
EP3448302B1 A method of making a dental restoration SOLVENTUM PROPERTIES 13 Aug, 2020
IVOCLAR VIVADENT
EP3245257B2 Surface-treated calcium carbonate with improved stability in environments with a ph of 4.5 to 7 OMYA 13 Aug, 2020
SCHAEFER KALK
EP2794024B2 Coloring agent comprising direct dyes and amphoteric surfactants HENKEL 12 Aug, 2020
LOREAL
EP2978426B1 Stable tigecycline composition INTAS PHARMACEUTICALS 11 Aug, 2020
FRESENIUS MEDICAL CARE DEUTSCHLAND
EP2906547B2 Cosmetic compositions containing at least one hydrotrope and at least one active compound LORAL 11 Aug, 2020
HENKEL
EP2767285B1 Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof OTSUKA PHARMACEUTICAL 11 Aug, 2020
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
(and 1 more)
EP3263571B2 Crystal form of (r)-n-methylnaltrexone bromide and uses thereof PROGENICS PHARMACEUTICALS 10 Aug, 2020
ISARPATENT PATENT UND RECHTSANWLTE BEHNISCH BARTH CHARLES HASSA PECKMANN UND PARTNER MBB
EP3246021B1 Apixaban formulations BRISTOL MYERS SQUIBB IRELAND UNLIMITED 07 Aug, 2020
ALFRED E TIEFENBACHER
(and 11 more)
EP3043658B1 Nutritional composition having lipophilic compounds with improved solubility and bioavailability ABBOTT LABORATORIES 07 Aug, 2020
NUTRICIA
EP1591105B1 Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations STADA ARZNEIMITTEL AG 06 Aug, 2020
(Expiration: Mar, 2025)
EMIL KIESSLING
(and 5 more)
EP3319693B2 Method of strengthening hair fibers and protecting dyed hair color from fading or wash-out HERCULES 06 Aug, 2020
HENKEL
EP3137041B2 Sunscreen having reduced tendency to stain textiles i BEIERSDORF 06 Aug, 2020
LOREAL
EP2934189B1 Human milk oligosaccharides to ameliorate symptoms of stress ABBOTT LABORATORIES 06 Aug, 2020
(Expiration: Dec, 2033)
SOCIT DES PRODUITS NESTL
EP3233043B1 Process for preparing hydrogels TEOXANE 05 Aug, 2020
ALLERGAN
(and 1 more)
EP3566695B1 Treatment of coccidiosis with intramuscular triazine compositions CEVA SANTE ANIMALE SA 05 Aug, 2020
(Expiration: Dec, 2033)
BAYER ANIMAL HEALTH
(and 1 more)
EP2898061B1 Probiotic compositions for the treatment of obesity and obesity-related conditions PROTHERA INC 05 Aug, 2020
(Expiration: Aug, 2033)
COMPAGNIE GERVAIS DANONE
EP3302565B1 Solid dosage forms of palbociclib PFIZER INC 05 Aug, 2020
(Expiration: May, 2036)
HEXAL
(and 5 more)
EP3386994B1 4,6-di-(o-thiophosphate)-inositol-1,2,3,5-tetra-o-sulfate for c. difficile infection ETH ZRICH 05 Aug, 2020
HGF
EP2905030B1 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof E R SQUIBB & SONS 05 Aug, 2020
REGENERON PHARMACEUTICALS
EP3288931B2 Certain protein kinase inhibitor CHONGQING FOCHON PHARMACEUTICAL 04 Aug, 2020
HANN MOORE CURLEY
EP1856051B1 Amorphous lercanidipine hydrochloride RECORDATI IRELAND LTD 04 Aug, 2020
(Expiration: Feb, 2026)
HEUMANN PHARMA GENERICA
(and 6 more)
EP1874873B1 Sparkle effect of unique particle size distribution BASF 31 Jul, 2020
ECKART
EP2862561B1 Method for conditioning hair with an aerosol cream mousse THE PROCTER & GAMBLE 30 Jul, 2020
KAO GERMANY
EP2862560B1 Aerosol cream mousse, method of treating hair and use THE PROCTER & GAMBLE 30 Jul, 2020
KAO GERMANY
EP3456342B1 Agent for use in the case of fructose intolerance VITACARE 30 Jul, 2020
STADA ARZNEIMITTEL
EP3142637B1 Keratin treatment formulations and methods OLAPLEX 29 Jul, 2020
LORAL
EP2346355B1 Nutritional compositions with large diameter lipid globules with a coating comprising polar lipids NUTRICIA NV 24 Jul, 2020
(Expiration: Sep, 2029)
FRESENIUS KABI DEUTSCHLAND
EP3083686B2 Methods of treating cancers using pd-1 axis binding antagonists and taxanes F HOFFMANN LA ROCHE AG 23 Jul, 2020
(Expiration: Dec, 2034)
ARES TRADING
(and 2 more)
EP3338751B1 Absorbent structure for absorbent articles THE PROCTER & GAMBLE 23 Jul, 2020
KIMBERLY CLARK WORLDWIDE
(and 1 more)
EP2349332B1 Methods and compositions for regulating iron homeostasis by modulation bmp-6 GENERAL HOSPITAL CORP 23 Jul, 2020
(Expiration: Nov, 2029)
MATHYS & SQUIRE
EP3033102B2 Peptide conjugated particles NORTHWESTERN UNIVERSITY 23 Jul, 2020
PHOSPHOREX
EP3269802B1 Compounds for improved viral transduction BLUEBIRD BIO 23 Jul, 2020
SCRIPT
(and 1 more)
EP3145488B1 Liquid pharmaceutical composition FRESENIUS KABI DEUTSCHLAND GMBH 22 Jul, 2020
(Expiration: May, 2035)
BIOGEN
(and 2 more)
EP3041476B2 Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis ELLODI PHARMACEUTICALS LP 22 Jul, 2020
DR FALK PHARMA
EP2252289B1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors MITSUBISHI TANABE PHARMA 22 Jul, 2020
ELKINGTON AND FIFE
EP2877144B1 Composition UNILEVER 22 Jul, 2020
HENKEL
EP2233127B1 Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations STADA ARZNEIMITTEL AG 21 Jul, 2020
(Expiration: Mar, 2025)
DIRK ROSSMANN
(and 7 more)
EP3313364B1 Hair treatment process KAO GERMANY 17 Jul, 2020
HENKEL
(and 1 more)
EP2059258B1 Arginine wash in protein purification using affinity chromatography WYETH LLC 17 Jul, 2020
(Expiration: Sep, 2027)
J A KEMP
(and 1 more)
EP2496220B1 Modified release formulation of lacosamide LUPIN 16 Jul, 2020
JAMES POOLE
EP2792715B1 Semi-synthetic or synthetic petroleum jelly AIGLON 16 Jul, 2020
(Expiration: Mar, 2034)
SASOL WAX
EP3285733B1 Methods for treating relaxed hair OLAPLEX 14 Jul, 2020
HENKEL
EP2785349B2 Combination treatment of cancer ASTRAZENECA 14 Jul, 2020
(Expiration: Nov, 2032)
TEVA PHARMACEUTICAL INDUSTRIES
EP3126390B1 Cd33 specific chimeric antigen receptors for cancer immunotherapy CELLECTIS 14 Jul, 2020
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP3113847B1 Anhydrous dyeing composition and process for dyeing hair KAO GERMANY 13 Jul, 2020
HENKEL
EP3251660B1 Apixaban formulations BRISTOL MYERS SQUIBB IRELAND UNLIMITED 13 Jul, 2020
KUTZENBERGER WOLFF & PARTNER
(and 9 more)
EP3331537B1 Prophylactic use of inulin against sinusitis SDZUCKER 09 Jul, 2020
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
EP2504002B1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin BOEHRINGER INGELHEIM INTERNATIONAL GMBH 09 Jul, 2020
(Expiration: Nov, 2030)
ELKINGTON AND FIFE
(and 1 more)
EP3300729B1 Therapeutic compositions containing macitentan ACTELION PHARMACEUTICALS 09 Jul, 2020
GENERICS UK
(and 2 more)
EP3030262B1 Combined pharmaceutical composition CYTUNE PHARMA 09 Jul, 2020
MARGARET DIXON
EP2928496B1 Crispr-based genome modification and regulation SIGMA ALDRICH CO LLC 09 Jul, 2020
(Expiration: Dec, 2033)
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
(and 7 more)
EP2906696B2 Methods for modulating c9orf72 expression IONIS PHARMACEUTICALS 09 Jul, 2020
RICHLY
(and 1 more)
EP3202914B2 Method for diagnosing a neurodegenerative disease THE UNIVERSITY OF MANCHESTER 09 Jul, 2020
STRAWMAN
EP2806877B1 Neuroactive steroid formulations and methods of treating cns disorders SAGE THERAPEUTICS 08 Jul, 2020
DR SCHN
EP2337472B1 A cosmetic or dermatological system with automatic adjustment of the properties of a preparation as a function of data transmitted by a transmitter external to the system LOREAL SA 08 Jul, 2020
(Expiration: Oct, 2029)
HENKEL
(and 1 more)
EP3192880B1 Nucleic acid agents for use in treating facioscapulohumeral dystrophy (fshd) LEIDS UNIVERSITAIR MEDISCH CENTRUM LUMC 08 Jul, 2020
(Expiration: Aug, 2031)
STRAWMAN
(and 1 more)
EP2187965B1 Psma binding ligand-linker conjugates and methods for using PURDUE RESEARCH FOUNDATION 07 Jul, 2020
(Expiration: Aug, 2028)
BOULT WADE TENNANT
(and 1 more)
EP3038654B1 New use NOVARTIS AG 06 Jul, 2020
(Expiration: Aug, 2034)
GENERICS UK
(and 8 more)
EP2196225B1 Water-soluble agents in acrylate-based preparations BEIERSDORF 06 Jul, 2020
HENKEL
(and 1 more)
EP3274685B1 Process for evaluating the mechanical performance of a filler gel TEOXANE 02 Jul, 2020
ALLERGAN
EP3334289B1 High throughput process for delivering semi-firm gel for poultry CLEARHO 02 Jul, 2020
CEVA SANTE ANIMALE
EP2694050B1 Tapentadol for treating pain associated with trigeminal neuralgia GRNENTHAL 02 Jul, 2020
GENERICS UK
EP2684565B1 Use of ulipristal acetate for treating uterine fibroids LABORATOIRE HRA PHARMA SAS 02 Jul, 2020
(Expiration: Jan, 2029)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 1 more)
EP3389404B1 Mixture of hmos SOCIT DES PRODUITS NESTL 02 Jul, 2020
NUTRICIA
(and 1 more)
EP3041454B2 Powder mixture, use of the powder mixture and powder jet device FERTON HOLDING 02 Jul, 2020
OROCHEMIE
(and 1 more)
EP3257500B1 Apixaban formulations BRISTOL MYERS SQUIBB IRELAND UNLIMITED 02 Jul, 2020
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 9 more)
EP3016631B1 Cosmetic composition LOREAL 01 Jul, 2020
BEIERSDORF
EP2978440B1 Treating fibrosis by inhibiting tl1a and diagnosing fibrosis by detecting il31ra CEDARS SINAI MEDICAL CENTER 01 Jul, 2020
(Expiration: Mar, 2034)
STRAWMAN
EP3236985B2 Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers IMMATICS BIOTECHNOLOGIES 25 Jun, 2020
ADAPTIMMUNE
EP2783689B1 Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent TOYO SUGAR REFINING 25 Jun, 2020
BITOP
EP3340990B1 Pharmaceutical combinations comprising (a) the cyclin dependent kinase 4/6 (cdk4/6) inhibitor lee011 (=ribociclib), and (b) the epidermal growth factor receptor (egfr) inhibitor erlotinib, for the treatment or prevention of cancer NOVARTIS AG 25 Jun, 2020
(Expiration: Aug, 2036)
GENERICS UK
EP3180363B2 Sirp-alpha immunoglobulin fusion proteins MERCK PATENT 24 Jun, 2020
SCRIPT
EP3227342B2 Proteinaceous heterodimer and use thereof DINGFU BIOTARGET 18 Jun, 2020
MARGARET DIXON
EP2538975B1 Immunoglobulin preparation and storage system for an immunoglobulin preparation CSL BEHRING 18 Jun, 2020
OCTAPHARMA
EP3050963B1 Process for production of polypeptide by regulation of assembly CHUGAI SEIYAKU KABUSHIKI KAISHA 18 Jun, 2020
SANOFI
(and 1 more)
EP3065571B1 Composition PROBIOTIX HEALTH 12 Jun, 2020
CLASADO BIOSCIENCES
EP3174526B2 Composition containing apomorphine and a divalent metal cation BRITANNIA PHARMACEUTICALS 10 Jun, 2020
EVER NEURO PHARMA
EP2780375B1 Binding molecules for bcma and cd3 AMGEN RESEARCH MUNICH 10 Jun, 2020
TENEOBIO
(and 7 more)
EP3341173B1 Mixing and molding method for filled thermosets from organically crosslinkable composite materials, in particular for dental purposes WOLTER HERBERT 08 Jun, 2020
SPLANEMANN PATENTANWLTE PARTNERSCHAFT
EP3170842B1 Immunologic effector cell of targeted cld18a2, and preparation method and use thereof CRAGE MEDICAL 04 Jun, 2020
BIONTECH CELL & GENE THERAPIES
EP3303307B1 New gadolinium chelate compounds for use in magnetic resonance imaging BAYER PHARMA 04 Jun, 2020
DE SIMONE & PARTNERS
EP3021691B1 Methods and systems for incorporating nicotine into oral products ALTRIA CLIENT SERVICES 04 Jun, 2020
FERTIN PHARMA
EP3295925B2 Composition for the permanent deformation of hair having reduced odour NOXELL 04 Jun, 2020
HENKEL
EP3313452B1 Method for preparing an injectable cross-linked hydrogel, hydrogel obtained; and use of the obtained hydrogel KYLANE LABORATOIRES 04 Jun, 2020
LABORATOIRES VIVACY
(and 1 more)
EP2547402B2 Hair care products containing conjugated unsaturated oils KAO 04 Jun, 2020
LORAL
(and 1 more)
EP3082959B1 Cosmetic hair cleaning composition HENKEL 03 Jun, 2020
LOREAL
(and 1 more)
EP3300724B1 Particle containing at least a volatile substance and process for its preparation ERBER 02 Jun, 2020
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3091071B1 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy PLURISTEM 02 Jun, 2020
STRAWMAN
EP3064508B2 Method of producing recombinant high molecular weight vwf in cell culture BAXALTA 28 May, 2020
JAMES POOLE
EP3346995B1 Therapeutic compositions for treatment of human immunodeficiency virus GILEAD SCIENCES 28 May, 2020
SANDOZ
(and 2 more)
EP3116527B1 Method for preparing human plasma proteins LFB SA 27 May, 2020
(Expiration: Mar, 2035)
CSL BEHRING
EP3272397B1 Agent for oxidative hair dye and method for stabilizing color tone of oxidative hair dye composition HOYU CO LTD 25 May, 2020
(Expiration: Jul, 2037)
HENKEL
(and 1 more)
EP3261485B1 Cosmetic product having a metal can, and the contents of same BEIERSDORF AG 25 May, 2020
(Expiration: Feb, 2036)
HENKEL
EP3186395B2 Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 25 May, 2020
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3024450B1 Compositions and methods using tiglic aldehyde SOCIT DES PRODUITS NESTL 25 May, 2020
NUTRICIA
EP3210592B1 Silica and dentifrice composition comprising the same EVONIK DEGUSSA GMBH 25 May, 2020
(Expiration: Feb, 2031)
PQ PQ SILICAS UK
EP3319587B1 Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine HIGHLIGHT THERAPEUTICS SL 25 May, 2020
TARGIMMUNE THERAPEUTICS
EP3081208B1 Skin care spray compositions comprising microfibrillated cellulose BORREGAARD 25 May, 2020
WEIDMANN HOLDING
EP2773334B1 Composition with sustained antimicrobial activity COLUMBIA UNIVERSITY OF NEW YORK 22 May, 2020
(Expiration: Nov, 2032)
HENKEL
EP2780374B1 Binding molecules for bcma and cd3 AMGEN RESEARCH MUNICH GMBH 22 May, 2020
(Expiration: Nov, 2032)
KNIG SZYNKA TILMANN VON RENESSE
(and 6 more)
EP2498756B2 Tablet formulations of neratinib maleate WYETH 21 May, 2020
COOKE
EP2874624B8 Injectable antibiotic formulations and their methods of use ELANCO NEW ZEALAND 21 May, 2020
OMNIPHARM DEVELOPMENTS
(and 1 more)
EP2928455B1 Treatment of coccidiosis with intramuscular triazine compositions CEVA SANT ANIMALE 20 May, 2020
BAYER ANIMAL HEALTH
(and 1 more)
EP3395331B1 Pharmaceutical tablet composition comprising eltrombopag olamine ALFRED E TIEFENBACHER GMBH AND CO KG 20 May, 2020
(Expiration: Jul, 2037)
BLLE DR
EP2614835B1 Vaccination with multiple clades of H5 influenza A virus SEQIRUS UK LTD 20 May, 2020
(Expiration: Nov, 2028)
GLAXOSMITHKLINE BIOLOGICALS
EP3049108B2 Dry formulations of vaccines that are room temperature stable INTERVET 20 May, 2020
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
EP2964215B1 Mixture of fatty acids for use in the treatment of inflammatory pathologies AGAIN LIFE ITALIA 20 May, 2020
NUTRICIA
EP2266422B1 Synergism of GOS and polyfructose NUTRICIA NV 20 May, 2020
(Expiration: May, 2025)
SOCIT DES PRODUITS NESTL
EP2846761B1 Composition comprising (2,5-diaminophenyl)ethanol, an alkylpolyglucoside nonionic surfactant, an oxyethylenated sorbitan ester or a polyalkoxylated or polyglycerolated fatty alcohol in a medium rich in fatty substances, dyeing process and device therefore LOREAL 19 May, 2020
HENKEL
EP3283050B1 Hair dyeing composition KAO GERMANY 19 May, 2020
LORAL
EP3031920B1 Modulation of dystrophia myotonica-protein kinase (dmpk) expression IONIS PHARMACEUTICALS INC 19 May, 2020
(Expiration: Jul, 2031)
STRAWMAN
EP3141284B1 Method of straightening keratinous fibers using heating means and an acid derivative LORAL 18 May, 2020
HENKEL
EP3148646B2 Cosmetic composition for make up and for taking care of keratin materials LORAL 15 May, 2020
HENKEL
EP3225233B1 Sodium chloride solution for drug reconstitution WYETH LLC 14 May, 2020
(Expiration: Oct, 2026)
BIOVERATIV THERAPEUTICS
(and 1 more)
EP3133070B1 Eliglustat (genz 112638) as inhibitor of glucosylceramide synthase for use in a method of treating fabry's or gaucher's disease, the method comprising adjusting the individual therapeutical dose to the p-450 metabolism of the patient GENZYME 14 May, 2020
HETERO LABS
(and 2 more)
EP3024461B1 A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation EURO CELTIQUE SA 14 May, 2020
(Expiration: Jul, 2034)
HEXAL PHARMA
(and 1 more)
EP2970123B1 Salt of omecamtiv mecarbil and process for preparing salt AMGEN 14 May, 2020
KELTIE
EP3273957B1 Biotin for treating amyotrophic lateral sclerosis MEDDAY PHARMACEUTICALS 14 May, 2020
NUTRICIA
EP2676967B1 Methods of treating inflammatory and autoimmune diseases with natalizumab BIOGEN MA INC 14 May, 2020
(Expiration: Feb, 2027)
POLPHARMA BIOLOGICS
EP3143985B1 Use of probiotic microorganisms to reduce skin irritation SOCIETE DES PRODUITS NESTLE SA 14 May, 2020
(Expiration: Mar, 2030)
SOFAR
(and 2 more)
EP3436054B2 Stabilized non-protein clostridial toxin compositions ALLERGAN 12 May, 2020
IPSEN PHARMA
EP3432916B1 Stabilized non-protein clostridial toxin compositions ALLERGAN 12 May, 2020
IPSEN PHARMA
EP2621481B2 Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases EXELIXIS 12 May, 2020
TEVA PHARMACEUTICAL INDUSTRIES
EP3116535B1 Combination of vaccination and ox40 agonists CUREVAC 07 May, 2020
BIONTECH RNA PHARMACEUTICALS
EP3087095B1 Fcrn antagonists and methods of use ARGENX BVBA 07 May, 2020
SANOFI
EP2869843B1 Complexes of cytomegalovirus proteins GLAXOSMITHKLINE BIOLOGICALS 07 May, 2020
(Expiration: Jun, 2033)
SANOFI PASTEUR
(and 1 more)
EP3160428B1 A sebum-promoting agent for improving hair UNILEVER PLC 07 May, 2020
(Expiration: Jun, 2035)
THE PROCTER & GAMBLE
EP2266549B1 Method of making particles for use in a pharmaceutical composition VECTURA LTD 06 May, 2020
(Expiration: Jun, 2021)
GLAXO GROUP
EP2713998B2 Process for treating straightened keratin fibres LOREAL 06 May, 2020
HENKEL
EP2679681B2 Fc riib-specific fc antibody CHUGAI SEIYAKU KABUSHIKI KAISHA 06 May, 2020
HGF
EP3018211B1 Antisense nucleic acids NIPPON SHINYAKU CO LTD 06 May, 2020
(Expiration: Aug, 2031)
SAREPTA THERAPEUTICS
(and 1 more)
EP2371361B1 Methods to mobilize progenitor/stem cells GENZYME 06 May, 2020
TEVA PHARMACEUTICAL INDUSTRIES
(and 6 more)
EP2651400B2 Controlled release oral dosage forms of poorly soluble drugs and uses thereof AMGEN EUROPE 06 May, 2020
TEVA PHARMACEUTICAL INDUSTRIES
EP2419144B1 Composition for delivery of genetic material OXFORD UNIVERSITY INNOVATION 06 May, 2020
TRUSCOTT
(and 1 more)
EP3342411B1 Rapamycin derivative for treating pancreas cancer NOVARTIS PHARMA AG 05 May, 2020
(Expiration: Feb, 2022)
GENERICS UK
(and 9 more)
EP2292252B1 Unitary combination of FSH and hCG FERRING BV 05 May, 2020
(Expiration: Jun, 2024)
MERCK SERONO
EP3027186B1 Composition comprising hyaluronic acid and mepivacaine TEOXANE 04 May, 2020
LABORATOIRES VIVACY
(and 2 more)
EP2635299B1 Methods for treating hair loss disorders THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 30 Apr, 2020
CONCERT PHARMACEUTICALS
EP3066472B1 Compositions and methods for detecting and/or treating inflammation THE GENERAL HOSPITAL 30 Apr, 2020
DR H ULRICH DRRIES
EP3150610B1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one PFIZER INC 30 Apr, 2020
(Expiration: Feb, 2031)
GENERICS UK
EP3372093B2 Process for obtaining citrus fiber from citrus peel CARGILL INCORPORATED 30 Apr, 2020
HERBSTREITH & FOX PECTIN FABRIKEN
(and 1 more)
EP3240554B1 Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases 4D PHARMA RESEARCH LTD 30 Apr, 2020
(Expiration: Jun, 2036)
HOFFMANN EITLE
EP2950816B1 The use of dna sequences encoding an interferon as vaccine adjuvants SCHWEITZER BIOTECH CO LTD 30 Apr, 2020
(Expiration: Feb, 2034)
ZOETIS SERVICES
EP3316854B1 Composition comprising multiple populations of microcapsules comprising perfume THE PROCTER & GAMBLE 29 Apr, 2020
HENKEL
(and 1 more)
EP2760425B8 Foam oxidative hair colorant composition with the free-base of 1, 4-diamino-2-methoxymethyl benzene NOXELL CORP 29 Apr, 2020
(Expiration: Sep, 2032)
HENKEL
EP3403654B1 Orally administered corticosteroid compositions ELLODI PHARMACEUTICALS LP 28 Apr, 2020
DR FALK PHARMA
EP3137042B1 Sunscreen having reduced tendency to stain textiles ii BEIERSDORF 28 Apr, 2020
LOREAL
EP2588589B2 Detergent product THE PROCTER & GAMBLE 27 Apr, 2020
HENKEL
EP3027174B1 Pharmaceutical compositions of fingolimod AIZANT DRUG RES SOLUTIONS PRIVATE LTD 24 Apr, 2020
(Expiration: Dec, 2033)
DF MP DRRIES FRANK MOLNIA & POHLMAN
EP2897611B1 Methods for treating hepatitis c ABBVIE 24 Apr, 2020
LUIGI
EP2991675B1 Campylobacter vaccine THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 23 Apr, 2020
DR KASCHE
EP3384931B1 Formoterol superfine formulation CHIESI FARMACEUTICI 23 Apr, 2020
LUPIN HEALTHCARE UK
EP2282764B1 Liver-specific nucleic acid regulatory elements and methods and use thereof VIB VZW 23 Apr, 2020
PFIZER
(and 1 more)
EP2768484B1 Lyophilized liposomes JAZZ PHARMACEUTICALS RESEARCH 23 Apr, 2020
SANDOZ
(and 1 more)
EP3210610B1 Formulations containing triazinones and iron BAYER ANIMAL HEALTH 22 Apr, 2020
CEVA SANTE ANIMALE
EP2784084B2 Antagonist antibodies to IL-17A/F heterologous polypeptides NOVARTIS PHARMA AG 22 Apr, 2020
(Expiration: Jun, 2024)
MERCK PATENT
(and 3 more)
EP2991507B1 Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer SMARTFISH 22 Apr, 2020
NUTRICIA
EP3370683B1 Antiperspirant compositions UNILEVER 22 Apr, 2020
THE PROCTER & GAMBLE
EP3093006B1 Alcohol containing sunscreen product without octocrylene BEIERSDORF 21 Apr, 2020
BASF
(and 2 more)
EP3103448B1 Pharmaceutical compositions comprising an s1p modulator NOVARTIS 20 Apr, 2020
(Expiration: Sep, 2027)
KRAUS & WEISERT PATENTANWLTE PARTGMBB
(and 6 more)
EP2651249B1 Whey protein composition with a reduced astringency NUTRICIA 20 Apr, 2020
SOCIT DES PRODUITS NESTL
(and 1 more)
EP3199146B1 Risperidone sustained release microsphere composition SHAN DONG LUYE PHARMACEUTICAL 17 Apr, 2020
ALKERMES PHARMA IRELAND
(and 1 more)
EP3326641B1 Rna containing composition for treatment of tumor diseases CUREVAC 17 Apr, 2020
FRIEDRICH
(and 3 more)
EP3072499B1 Octocrylene-free sunscreen with low adhesion BEIERSDORF AG 17 Apr, 2020
(Expiration: Jan, 2035)
LOREAL
(and 2 more)
EP3110433B2 Treatment of retinal degeneration using gene therapy THE UNIVERSITY OF MANCHESTER 17 Apr, 2020
STRATAGEM
(and 1 more)
EP2832350B1 Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose DAICEL 16 Apr, 2020
BAYER BAYER BAYER PHARMA
EP2814450B1 Stable water-in-oil emulsions with hlb-type emulsifiers BEIERSDORF AG 16 Apr, 2020
(Expiration: Feb, 2033)
EVONIK OPERATIONS
EP3093008B1 Octocrylene-free sunscreen agent containing diethylaminohydroxybenz oylhexylbenzoate BEIERSDORF 16 Apr, 2020
LOREAL
(and 5 more)
EP2544668B1 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device RANI THERAPEUTICS 16 Apr, 2020
NOVO NORDISK
EP3225230B1 Octocrylene-free sunscreen agent comprising diethylhexylbutamidotriazone BEIERSDORF 16 Apr, 2020
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 5 more)
EP3312196B1 Antibodies against cd38 for treatment of multiple myeloma GENMAB AS 16 Apr, 2020
(Expiration: Mar, 2026)
SECERNA
EP2563508B1 Delivery particle PROCTER AND GAMBLE CO 09 Apr, 2020
(Expiration: May, 2030)
HENKEL
EP2714071B1 Individualized vaccines for cancer BIONTECH 09 Apr, 2020
IPRIME RENTSCH KAELIN
(and 2 more)
EP3248600B8 Combinations and modes of administration of therapeutic agents and combination therapy ABRAXIS BIOSCIENCE LLC 09 Apr, 2020
(Expiration: Feb, 2026)
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP1797886B1 Immunostimulation by chemically modified RNA CUREVAC AG 09 Apr, 2020
(Expiration: Jul, 2023)
WEINZIERL
(and 1 more)
EP3002298B1 Anti-factor xi monoclonal antibodies and methods of use thereof OREGON HEALTH SCIENCE UNIVERSITY 08 Apr, 2020
(Expiration: Nov, 2028)
MERCK SHARP & DOHME
EP2694834B2 Keratin-based hair straightening formulations, methods and systems BAUM MARC MICHAEL 07 Apr, 2020
HENKEL
EP2866776B1 Two coat process for dyeing keratin fibres LOREAL 07 Apr, 2020
HENKEL
(and 1 more)
EP2861087B1 Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat NUTRICIA 06 Apr, 2020
SOCIT DES PRODUITS NESTL
(and 1 more)
EP3079474B1 Antiparasitic use of isoxazoline compounds INTERVET 03 Apr, 2020
CEVA SANTE ANIMALE
(and 1 more)
EP3076939B1 Agent for oxidatively dyeing hair containing specific combinations of developers and couplers HENKEL 03 Apr, 2020
KAO GERMANY
(and 1 more)
EP2104490B1 Micronised particles of low-dosage strength active agents for powder formulations for inhalation CHIESI FARMACEUTICI 03 Apr, 2020
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
EP3024448B8 Compositions and methods using p-anisaldehyde SOCIT DES PRODUITS NESTL 03 Apr, 2020
NUTRICIA
EP2907497B1 Cosmetic emulsifier combination BEIERSDORF 02 Apr, 2020
BASF
EP3270871B1 Cosmetic compositions comprising a talc particulate IMERTECH SAS 02 Apr, 2020
(Expiration: Mar, 2036)
IMI FABI
EP2919823B1 Antimicrobial articles produced by additive manufacturing ORTHOPAEDIC INNOVATION CENTRE 01 Apr, 2020
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP2651958B2 Glycoside blends CARGILL INCORPORATED 31 Mar, 2020
J A KEMP
EP3076983B1 Ionic aqueous compositions GEROLYMATOS 30 Mar, 2020
MARINOMED BIOTECH
(and 1 more)
EP3173092B1 Rna containing composition for treatment of tumor diseases CUREVAC 26 Mar, 2020
FRIEDRICH
(and 4 more)
EP2873733B2 Vectors for transforming mycoplasma hyopneumoniae, transformed m. hyopneumoniae strains, and use thereof HIPRA SCIENTIFIC SLU 26 Mar, 2020
INTERVET
EP2884979B1 Combination therapies for melanoma comprising administering cobimetinib and vemurafinib F HOFFMANN LA ROCHE 24 Mar, 2020
(Expiration: Aug, 2033)
SANDOZ
EP2380581B1 Muscle-building agent MEGMILK SNOW BRAND CO LTD 23 Mar, 2020
(Expiration: Dec, 2029)
FRESENIUS KABI DEUTSCHLAND
(and 2 more)
EP3068437B2 Sprayable topical carrier and composition comprising phosphatidylcholine LIPIDOR 19 Mar, 2020
BEIERSDORF
EP2687213B1 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof CELGENE CORP 19 Mar, 2020
(Expiration: Mar, 2028)
GENERICS UK
EP2911684B1 Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes NOVARTIS 19 Mar, 2020
(Expiration: Oct, 2033)
GRAF VON STOSCH
EP2968221B1 Pharmaceutical composition of s-ketamine hydrochloride JANSSEN PHARMACEUTICA NV 18 Mar, 2020
(Expiration: Mar, 2034)
ASPIRE PHARMA
(and 1 more)
EP3153179B1 Optimised injection formulation for mrna CUREVAC 18 Mar, 2020
ETHERNA IMMUNOTHERAPIES
(and 1 more)
EP3233030B1 Composition in the form of o/w emulsion LOREAL SA 17 Mar, 2020
(Expiration: Dec, 2035)
HENKEL
(and 1 more)
EP2358642B2 Method for reducing the concentration of amines and salts thereof FROXIMUN 16 Mar, 2020
GLOCK HEALTH
EP3138916B1 Immunogenic composition GLAXOSMITHKLINE BIOLOGICALS SA 16 Mar, 2020
(Expiration: May, 2032)
VALNEVA AUSTRIA
EP2374452B1 Nutrient composition AJINOMOTO 13 Mar, 2020
FRESENIUS KABI DEUTSCHLAND
EP2841054B2 Injectable preparation OTSUKA PHARMACEUTICAL 13 Mar, 2020
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2488033B1 Combination comprising an MEK inhibitor and a B-raf inhibitor NOVARTIS 12 Mar, 2020
(Expiration: Oct, 2030)
GENERICS UK
(and 1 more)
EP3034073B1 Use of a composition comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma CHIESI FARMACEUTICI 12 Mar, 2020
LUPIN HEALTHCARE UK
(and 2 more)
EP2836196B1 Preparation for topical application to mucosa containing polyhexanide as active ingredient MERZ PHARMA GMBH AND CO KGAA 12 Mar, 2020
(Expiration: Apr, 2033)
MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
EP2640413B1 A process for reduction and/or removal of fxi and fxia from solutions containing said coagulation factors OCTAPHARMA 12 Mar, 2020
STRAWMAN
EP1687308B1 Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride MERCK & CIE 11 Mar, 2020
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3179989B1 Silicone-containing acrylic polymers for transdermal drug delivery compositions NOVEN PHARMACEUTICALS INC 11 Mar, 2020
(Expiration: Jul, 2035)
LTS LOHMANN THERAPIE SYSTEME
EP2863876B1 Hair colorant compositions comprising 2-methoxymethyl-1,4-diaminobenzene, methods, and kits NOXELL CORP 10 Mar, 2020
(Expiration: Jun, 2033)
HENKEL
EP2787965B1 Composition based on red henna powder and oil(s), and hair dyeing process using this composition LOREAL SA 09 Mar, 2020
(Expiration: Dec, 2032)
HENKEL
(and 1 more)
EP2678011B1 Antitumoral combination comprising cabazitaxel and cisplatin AVENTIS PHARMA SA 05 Mar, 2020
(Expiration: Feb, 2032)
GENERICS UK
EP2877201B1 A liquid formulation of long-acting insulin and insulinotropic peptide HANMI PHARM 05 Mar, 2020
JAMES POOLE
EP3024479B2 High potency pancreatin pharmaceutical compositions ALLERGAN PHARMACEUTICALS 05 Mar, 2020
MATHYS & SQUIRE
EP2780022B2 Pharmaceutical preparations of human rpe cells and uses thereof ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE 05 Mar, 2020
STRAWMAN
EP2223688B1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof CELGENE CORP 02 Mar, 2020
(Expiration: Mar, 2023)
GALENICUM HEALTH SLU
(and 4 more)
EP2720757B1 Preparations that conform to the principles of organic cosmetics BEIERSDORF 28 Feb, 2020
FA SCHWANHUER INDUSTRIE HOLDING
EP2812443B1 Cd47 antibodies and methods of use thereof INHIBRX 28 Feb, 2020
FORTY SEVEN
EP2448551B1 Ester mixtures and compositions comprising such ester mixtures COGNIS IP MANAGEMENT GMBH 28 Feb, 2020
(Expiration: Jun, 2030)
KADOR & PARTNER PARTG MBB
EP2879656B1 Dye composition in cream form comprising at least one oil and little or no solid fatty alcohol, dyeing process and suitable device LOREAL 28 Feb, 2020
KAO GERMANY
EP3019180B1 Beta-casein a2 and reducing or preventing symptoms of lactose intolerance THE A MILK 28 Feb, 2020
NUTRICIA
EP3116534B1 Compositions of human prothrombin and activated factor x for improving hemostasis in the treatment of bleeding disorders BAXALTA GMBH 28 Feb, 2020
(Expiration: Mar, 2035)
OCTAPHARMA
EP2658391B1 Non-medical increase or maintenance of body weight of a mammal NUTRICIA 25 Feb, 2020
SOCIT DES PRODUITS NESTL
EP2687103B1 Aqueous transparent oil-in-water emulsion comprising an emulsified carotenoid BASF 24 Feb, 2020
DSM NUTRITIONAL PRODUCTS
EP3351246B8 Rapamycin derivative for the treatment of a solid tumor associated with deregulated angiogenesis NOVARTIS PHARMA AG 21 Feb, 2020
(Expiration: Feb, 2022)
GENERICS UK
(and 9 more)
EP3143998B1 An inhalable medicament comprising tiotropium TEVA BRANDED PHARMACEUTICAL PRODUCTS R & D 21 Feb, 2020
M INNOVATIVE PROPERTIES
EP2787078B1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain CHUGAI PHARMACEUTICAL CO LTD 21 Feb, 2020
(Expiration: Oct, 2032)
STRAWMAN
EP3212296B1 Anhydrous antiperspirant aerosol compositions UNILEVER 21 Feb, 2020
THE PROCTER & GAMBLE
EP3176240B2 Process for preparing alcohol ether sulfates CHEVRON ORONITE 20 Feb, 2020
SASOL PERFORMANCE CHEMICALS
EP2819699B1 Controlled release compositions and their methods of use ELANCO NEW ZEALAND 19 Feb, 2020
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2289531B1 Medicaments for increasing endogenous erythropoietine (epo) FIBROGEN 19 Feb, 2020
GLAXOSMITHKLINE UK
(and 1 more)
EP2892528B1 Pharmaceutical compositions comprising flurbiprofen RECKITT BENCKISER HEALTHCARE 17 Feb, 2020
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
EP2400950B1 Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol GLAXO GROUP 14 Feb, 2020
ARVEN ILAC SANAYI VE TICARET
(and 7 more)
EP2825558B1 Combination therapy for the treatment of ovarian cancer F HOFFMANN LA ROCHE AG 14 Feb, 2020
(Expiration: Mar, 2033)
MABXIENCE RESEARCH
(and 8 more)
EP3065777B2 Methods of use for il-22 in the treatment of gastrointestinal graft vs. host disease MEMORIAL SLOAN KETTERING CANCER CENTER 14 Feb, 2020
STRAWMAN
EP3003485B1 Composition comprising beta-casein a2 for use in the prevention of inflammation of the bowel A2 MILK CO LTD 13 Feb, 2020
(Expiration: May, 2034)
FRESENIUS KABI DEUTSCHLAND
(and 1 more)
EP2766040B1 Pertuzumab, trastuzumab, docetaxel and carboplatin for the treatment of early-stage breast cancer F HOFFMANN LA ROCHE AG 13 Feb, 2020
(Expiration: Oct, 2032)
KNIG SZYNKA TILMANN VON RENESSE
(and 8 more)
EP2111416B2 Iron-hydrocarbon complex compounds VIFOR 13 Feb, 2020
NUTRICIA
EP3016666B1 A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease SMARTFISH AS 13 Feb, 2020
(Expiration: Jun, 2034)
NUTRICIA
EP2865376B2 Adhesive preparation composition obtained by blending drug, organic solvent, lipophilic ointment base, and powder MEDRX 11 Feb, 2020
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP1294379B1 A new use for deferiprone APOTEX INC 11 Feb, 2020
(Expiration: Jun, 2021)
LIPOMED
EP2324834B1 Methods of Increasing Endogenous Erythropoietin (EPO) FIBROGEN INC 10 Feb, 2020
(Expiration: Dec, 2022)
AKEBIA THERAPEUTICS
EP2506825B2 Hatching fluid enzymes and uses thereof AQUA BIO TECHNOLOGY ASA 10 Feb, 2020
REGENICS
EP2347762B1 Exendin for treating diabetes and reducing body weight AMYLIN PHARMACEUTICALS LLC 07 Feb, 2020
(Expiration: Aug, 2026)
GENERICS UK
(and 1 more)
EP3068396B1 Rapidly disintegrating formulations and methods of use IMPAX LABORATORIES LLC 07 Feb, 2020
(Expiration: Nov, 2034)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP2533751B1 Composition for cleaning teeth comprising natural glass and related methods IMERYS FILTRATION MINERALS 07 Feb, 2020
NORDISK PERLITE APS
EP2790706B1 Phytoecdysones for use in improving the muscle quality of obese and/or sarcopenic mammals BIOPHYTIS 07 Feb, 2020
VIDON BREVETS & STRATGIE
EP2897588B1 An inhalable medicament TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D 06 Feb, 2020
CHIESI FARMACEUTICI
EP3344607B1 Solid state forms of selexipag TEVA PHARMACEUTICALS 06 Feb, 2020
CHIESI FARMACEUTICI
(and 1 more)
EP3284520B1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity VIIV HEALTHCARE 04 Feb, 2020
GILEAD SCIENCES
EP2912074B2 Dermal injectable sterile composition TEOXANE 03 Feb, 2020
ALLERGAN
EP2626058B1 Dental canaliculi sealing agent and method for producing the same KURARAY NORITAKE DENTAL 03 Feb, 2020
OMYA
EP3292873B1 Combination of vaccination and inhibition of the pd-1 pathway CUREVAC 03 Feb, 2020
PFIZER
(and 5 more)
EP1991688B1 Biodegradable compositions comprising renewably-based, biodegradable 1.3-propanediol PRIMIENT COVATION 31 Jan, 2020
DSM NUTRITIONAL PRODUCTS
EP2451482B1 Combination therapy for the treatment of diabetes JANSSEN PHARMACEUTICA NV 31 Jan, 2020
(Expiration: Jul, 2030)
GENERICS UK
(and 1 more)
EP3043768B2 Method for the treatment of hair from a composition comprising an organic monoacid and a cellulosic polymer LOREAL 31 Jan, 2020
KAO GERMANY
(and 1 more)
EP2649982B1 Hair bleaching composition and method for producing same ARTEC CHEMICAL CO LTD 31 Jan, 2020
(Expiration: Mar, 2033)
KAO GERMANY
(and 1 more)
EP2344141B1 Compositions comrrising amlodipine and bisoprolol EGYT GYOGYSZERVEGYESZETI GYAR 31 Jan, 2020
(Expiration: Sep, 2029)
KRKA
EP2742803B1 Isothiazolinone biocides enhanced by metal ions ARCH CHEMICALS 31 Jan, 2020
PPG INDUSTRIES
EP2968549B2 Methods of cell culture MOMENTA PHARMACEUTICALS 31 Jan, 2020
REGENERON PHARMACEUTICALS
(and 1 more)
EP3166572B1 Anti-calculus oral compositions PROCTER AND GAMBLE CO 31 Jan, 2020
(Expiration: Jul, 2034)
TRSCH
EP1317918B1 Cosmetic sunscreen compositions based on synergistic filter mixture and their use LOREAL SA 30 Jan, 2020
(Expiration: Nov, 2022)
STADA ARZNEIMITTEL
EP3177323B2 Photo-controlled removal of targets in vitro and in vivo THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES 30 Jan, 2020
STRAWMAN
EP3129485B2 Crispr/cas-related methods and compositions for treating cystic fibrosis EDITAS MEDICINE 28 Jan, 2020
JAMES POOLE
EP2953621B1 Topical antifungal composition for treating onychomycosis POLICHEM 28 Jan, 2020
WILSON GUNN
EP3373914B2 Storage stable composition comprising rifaximin alpha SANDOZ 24 Jan, 2020
ALFASIGMA
EP2658514B2 Cleansing composition especially for artificially coloured hair KAO GERMANY 24 Jan, 2020
HENKEL
EP2494983B1 Stable formulations of glp-1 NOVO NORDISK AS 24 Jan, 2020
(Expiration: Nov, 2025)
HOFFMANN EITLE
(and 1 more)
EP2872533B1 Methods of assessing the suitability of transduced t cells for administration UNIVERSITY OF PENNSYLVANIA PENN 24 Jan, 2020
(Expiration: Jul, 2033)
PATENT BOUTIQUE
(and 1 more)
EP3209387B1 Use of chitosans in antiperspirant compositions free of halogen or halogenhydroxysalts of aluminum and or zirconium HENKEL AG AND CO KGAA 24 Jan, 2020
(Expiration: Sep, 2035)
THE PROCTER & GAMBLE
EP3234025B1 Red-coloured decorative pigments with high chroma and high brilliancy, method for their production and use of same ECKART 23 Jan, 2020
BASF COLORS & EFFECTS
EP2800476B1 Method of feeding DUPONT NUTRITION BIOSCIENCES APS 23 Jan, 2020
NOVOZYMES
EP3049056B2 Antifungal topical composition and methods of treatment BLUEBERRY THERAPEUTICS 23 Jan, 2020
WILSON GUNN
EP3494997B1 Inducible dna binding proteins and genome perturbation tools and applications thereof THE BROAD INSTITUTE 21 Jan, 2020
GRUND
(and 3 more)
EP3273934B1 Method for cosmetic treatment of the hair LOREAL 20 Jan, 2020
HENKEL
(and 1 more)
EP3395339B8 Rapid dissolution formulation of a cinacalcet hcl AMGEN INC 17 Jan, 2020
(Expiration: Sep, 2024)
AECHTER
(and 10 more)
EP3140008B1 Rapid-acting insulin compositions ELI LILLY 17 Jan, 2020
COOKE
EP3056515B1 Methods for manipulating phagocytosis mediated by cd47 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 17 Jan, 2020
GENMAB
(and 3 more)
EP3260117B8 Rapid dissolution formulation comprising cinacalcet hcl AMGEN INC 17 Jan, 2020
(Expiration: Sep, 2024)
HGF
(and 6 more)
EP3056514B1 Methods for manipulating phagocytosis mediated by cd47 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 17 Jan, 2020
MATHYS & SQUIRE
(and 3 more)
EP3395340B8 Rapid dissolution formulation of cinacalcet hcl AMGEN INC 16 Jan, 2020
(Expiration: Sep, 2024)
GLENMARK PHARMACEUTICALS EUROPE
(and 8 more)
EP2190434B1 Purin derivatives for use in the treatment of fap-related diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH 16 Jan, 2020
(Expiration: Aug, 2028)
HEXAL
EP2957280B1 Solid pharmaceutical composition of cytisine and process for preparation thereof AFLOFARM FARMACJA POLSKA SP Z OO 16 Jan, 2020
SOPHARMA AD
(and 1 more)
EP3318248B1 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases TRANSLATE BIO 10 Jan, 2020
BRADY
(and 1 more)
EP3186281B1 Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor HALOZYME INC 10 Jan, 2020
(Expiration: Aug, 2035)
J A KEMP
EP2173324B1 Hyaluronic acid injectable gel for treating joint degeneration APTISSEN 10 Jan, 2020
LABORATOIRES VIVACY
EP2322517B1 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) WISTA LABORATORIES 10 Jan, 2020
PROVEPHARM LIFE SOLUTIONSPROVEPHARM
(and 1 more)
EP2892558B1 Vista modulators for diagnosis and treatment of cancer THE TRUSTEES OF DARTMOUTH COLLEGE 10 Jan, 2020
REGIMBEAU
EP2962686B1 Dosage form containing oxycodone and naloxone EURO CELTIQUE SA 09 Jan, 2020
(Expiration: Feb, 2026)
ARISTO PHARMA
(and 6 more)
EP2460820B8 Pcv2 immunogenic compositions and methods of producing such compositions BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC 09 Jan, 2020
(Expiration: Dec, 2025)
CEVA SANTE ANIMALE
(and 2 more)
EP3351240B1 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione CELGENE 09 Jan, 2020
GENERICS UK
(and 3 more)
EP3107556B1 Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase UNIVERSITE DE LA ROCHELLE 07 Jan, 2020
(Expiration: Feb, 2035)
ARLA FOODS AMBA
EP3093009B1 Octocrylene-free sunscreen agent with diethylaminohydroxybenzoylhexylbenzoate BEIERSDORF AG 06 Jan, 2020
(Expiration: May, 2036)
DALLI WERKE
(and 4 more)
EP2734185B1 Dyeing process using a natural dye on keratin fibres that have undergone permanent reshaping LOREAL SA 06 Jan, 2020
(Expiration: Jul, 2032)
KAO GERMANY
EP2842569B1 One dose vaccination with Mycoplasma hyopneumoniae ZOETIS SERVICES LLC 03 Jan, 2020
(Expiration: Jun, 2022)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2859075B1 Biosolubilizer GIVAUDAN SA 03 Jan, 2020
(Expiration: May, 2033)
EVONIK OPERATIONS
(and 1 more)
EP2970493B1 Methods for achieving therapeutically effective doses of anti-cd47 agents THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 03 Jan, 2020
GENMAB
(and 1 more)
EP3401400B1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 03 Jan, 2020
GREAVES BREWSTER
(and 3 more)
EP2747748B1 Non-aqueous composition for hair KAO GERMANY 03 Jan, 2020
HENKEL
EP2819640B1 Use of powdered cellulose in cosmetic applications EVONIK OPERATIONS 03 Jan, 2020
MAYR KOTSCH PATENTANWALT RECHTSANWLTIN PARTNERSCHAFTSGESELLSCHAFT MBB
EP2113567B1 Microrna target site blocking oligos and uses thereof QIAGEN 03 Jan, 2020
RANGER BIOTECHNOLOGIES
EP2964203B1 Novel esterified cellulose ethers of very high molecular weight DOW 03 Jan, 2020
SHIN ETSU CHEMICAL
EP2723774B1 Method for manufacturing hydroxyethyl starch derivatives SERUMWERK BERNBURG 03 Jan, 2020
STRAWMAN
EP3165220B1 Pharmaceutical composition containing an anti-nucleating agent MERCK SHARP & DOHME 03 Jan, 2020
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 1 more)
EP3111954B1 Methods of treating ankylosing spondylitis using anti-il-17 antibodies NOVARTIS AG 02 Jan, 2020
(Expiration: Nov, 2031)
DR REDDYS LABORATORIES
(and 2 more)